NTRK2 and cancer: Three somatic, non-synonymous point mutations of TRKB have been reported in the early large-scale sequencing studies in human cancers: two in colorectal tumors, TRKBT695I and TRKBD751N[17], and one in a lung adenocarcinoma cell line, TRKBL138F[19].